{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:16:43Z","timestamp":1792019803876,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"publisher","award":["SKGJ-MED-024"],"award-info":[{"award-number":["SKGJ-MED-024"]}],"id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010586","name":"Haukeland\u00a0Universitetssjukehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012446","name":"Akershus Universitetssykehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021697","name":"Sykehuset i Vestfold","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007793","name":"Stiftelsen Kristian Gerhard Jebsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clinbiochem.2023.110688","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T03:27:35Z","timestamp":1700623655000},"page":"110688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The liver-heart axis in patients with severe obesity: The association between liver fibrosis and chronic myocardial injury may be explained by shared risk factors of cardiovascular disease"],"prefix":"10.1016","volume":"123","author":[{"given":"J.","family":"Young","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Seeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7340-6736","authenticated-orcid":false,"given":"K.M.","family":"Aakre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Borgeraas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1527-9772","authenticated-orcid":false,"given":"N.","family":"Nordstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Wisl\u00f8ff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1995-0562","authenticated-orcid":false,"given":"J.","family":"Hjelmes\u00e6th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Omland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.K.","family":"Hertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110688_b0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.amjmed.2019.09.002","article-title":"Atrial fibrillation and heart failure with preserved ejection fraction in patients with nonalcoholic fatty liver disease","volume":"133","author":"Packer","year":"2020","journal-title":"Am J Med"},{"issue":"36","key":"10.1016\/j.clinbiochem.2023.110688_b0010","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"M\u00f8ller","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110688_b0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110688_b0020","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J Hepatol"},{"issue":"16","key":"10.1016\/j.clinbiochem.2023.110688_b0025","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jacc.2016.01.070","article-title":"Nonalcoholic fatty liver disease and incident cardiac events: the multi-ethnic study of atherosclerosis","volume":"67","author":"Zeb","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"9669","key":"10.1016\/j.clinbiochem.2023.110688_b0030","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110688_b0035","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1373\/jalm.2018.027359","article-title":"Derivation and performance of standardized enhanced liver fibrosis (elf) test thresholds for the detection and prognosis of liver fibrosis","volume":"3","author":"Day","year":"2019","journal-title":"J Appl Lab Med"},{"issue":"10290","key":"10.1016\/j.clinbiochem.2023.110688_b0040","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110688_b0045","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/annrheumdis-2012-202843","article-title":"The enhanced liver fibrosis test: a clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis","volume":"73","author":"Abignano","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110688_b0050","first-page":"254","article-title":"European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis","volume":"58","author":"Abignano","year":"2019","journal-title":"Rheumatology (oxford)"},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110688_b0055","first-page":"262","article-title":"Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction, ESC Heart","volume":"5","author":"Yoshihisa","year":"2018","journal-title":"Fail"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110688_b0060","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2017-000598","article-title":"Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure","volume":"4","author":"Sato","year":"2017","journal-title":"Open Heart"},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110688_b0065","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCHEARTFAILURE.108.828343","article-title":"Association between elevated fibrosis markers and heart failure in the elderly: the cardiovascular health study","volume":"2","author":"Barasch","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110688_b0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.2010.02253.x","article-title":"New features of troponin testing in different clinical settings","volume":"268","author":"Omland","year":"2010","journal-title":"J Intern Med"},{"issue":"26","key":"10.1016\/j.clinbiochem.2023.110688_b0075","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"A sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.clinbiochem.2023.110688_b0080","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1161\/CIRCULATIONAHA.118.038529","article-title":"Cardiac Troponin T and Troponin I in the General Population","volume":"139","author":"Welsh","year":"2019","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.clinbiochem.2023.110688_b0085","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jacc.2012.12.026","article-title":"Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease","volume":"61","author":"Omland","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.clinbiochem.2023.110688_b0090","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033548","article-title":"Chronic troponin elevation assessed by myocardial T1 mapping in patients with stable coronary artery disease","volume":"102","author":"Segre","year":"2023","journal-title":"Medicine (baltimore)"},{"issue":"16","key":"10.1016\/j.clinbiochem.2023.110688_b0095","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/CIRCULATIONAHA.116.025505","article-title":"High-sensitive cardiac troponin t as an early biochemical signature for clinical and subclinical heart failure: mesa (multi-ethnic study of atherosclerosis)","volume":"135","author":"Seliger","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2023.110688_b0100","doi-asserted-by":"crossref","first-page":"1104715","DOI":"10.3389\/fcvm.2023.1104715","article-title":"Association of cardiac troponin T and growth differentiation factor 15 with replacement and interstitial cardiac fibrosis in community dwelling adults: the multi-ethnic study of atherosclerosis","volume":"10","author":"deFilippi","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.clinbiochem.2023.110688_b0105","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1080\/1354750X.2018.1490969","article-title":"Possible mechanisms behind cardiac troponin elevations","volume":"23","author":"Hammarsten","year":"2018","journal-title":"Biomarkers"},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110688_b0110","first-page":"553","article-title":"How is cardiac troponin released from injured myocardium?","volume":"7","author":"Mair","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"25","key":"10.1016\/j.clinbiochem.2023.110688_b0115","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.jacc.2017.10.044","article-title":"Association of elevated NT-proBNP with myocardial fibrosis in the multi-ethnic study of atherosclerosis (MESA)","volume":"70","author":"Liu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinbiochem.2023.110688_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104490","article-title":"Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis","volume":"90","author":"Bakhshi","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110688_b0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10408363.2018.1525335","article-title":"Novel biomarkers of cardiovascular disease: Applications in clinical practice","volume":"56","author":"Lyngbakken","year":"2019","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"9380","key":"10.1016\/j.clinbiochem.2023.110688_b0130","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","article-title":"B-type natriuretic peptide in cardiovascular disease","volume":"362","author":"de Lemos","year":"2003","journal-title":"Lancet"},{"issue":"36","key":"10.1016\/j.clinbiochem.2023.110688_b0135","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"37","key":"10.1016\/j.clinbiochem.2023.110688_b0140","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.clinbiochem.2023.110688_b0145","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110688_b0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jacc.2007.03.038","article-title":"Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial","volume":"50","author":"Omland","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.clinbiochem.2023.110688_b0155","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/ejhf.1209","article-title":"Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population","volume":"20","author":"Suthahar","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"10.1016\/j.clinbiochem.2023.110688_b0160","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1001\/archinte.164.20.2247","article-title":"Relationship between obesity and B-type natriuretic peptide levels","volume":"164","author":"McCord","year":"2004","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110688_b0165","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/emmm.201303800","article-title":"The heart-liver metabolic axis: defective communication exacerbates disease","volume":"6","author":"Baskin","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.clinbiochem.2023.110688_b0170","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2261-11-7","article-title":"The relationship between various measures of obesity and arterial stiffness in morbidly obese patients","volume":"11","author":"Nordstrand","year":"2011","journal-title":"BMC Cardiovasc Disord"},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110688_b0175","first-page":"690","article-title":"Arterial stiffness, lifestyle intervention and a low-calorie diet in morbidly obese patients-a nonrandomized clinical trial, Obesity (silver","volume":"21","author":"Nordstrand","year":"2013","journal-title":"Spring)"},{"key":"10.1016\/j.clinbiochem.2023.110688_b0180","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clinbiochem.2020.09.006","article-title":"Gastric bypass surgery is associated with reduced subclinical myocardial injury and greater activation of the cardiac natriuretic peptide system than lifestyle intervention","volume":"86","author":"Aakre","year":"2020","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110688_b0185","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-022-01756-1","article-title":"Differential effects of bariatric surgery and lifestyle interventions on plasma levels of Lp(a) and fatty acids","volume":"21","author":"Berk","year":"2022","journal-title":"Lipids Health Dis"},{"issue":"Suppl 1","key":"10.1016\/j.clinbiochem.2023.110688_b0190","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.2337\/dc08-S055","article-title":"Diagnosis and classification of diabetes mellitus","volume":"31","author":"American Diabetes Association","year":"2008","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.clinbiochem.2023.110688_b0195","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinbiochem.2023.110688_b0200","doi-asserted-by":"crossref","unstructured":"Alberti, K.G., et al., Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009. 120(16): p. 1640-5.","DOI":"10.1161\/CIRCULATIONAHA.109.192644"},{"key":"10.1016\/j.clinbiochem.2023.110688_b0205","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"Lipid modification to reduce cardiovascular risk","volume":"290","author":"2019 ESC\/EAS guidelines for the management of dyslipidaemias","year":"2019","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110688_b0210","first-page":"37","article-title":"Effects of intensive lifestyle intervention and gastric bypass on aortic stiffness: a 1-year nonrandomized clinical study, Obesity (Silver Spring)","volume":"23","author":"Gjevestad","year":"2015"},{"issue":"02","key":"10.1016\/j.clinbiochem.2023.110688_b0215","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/a-0713-1330","article-title":"Noninvasive liver fibrosis tests in patients with nonalcoholic fatty liver disease: an external validation cohort","volume":"51","author":"Polyzos","year":"2019","journal-title":"Horm Metab Res"},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110688_b0220","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinbiochem.2023.110688_b0225","unstructured":"medicine, I.f.o.c.c.a.l. high-sensitivity cardiac troponin I and T assay -analytical characteristics. 2021; Available from: https:\/\/pub-180a8d00f517477ba49634e6b2b147e3.r2.dev\/2023\/11\/High-Sensitivity-Cardiac-Troponin-I-and-T-Assay-Analytical-Characteristics-Designated-By-Manufacturer-v092021-3.pdf."},{"key":"10.1016\/j.clinbiochem.2023.110688_b0230","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110688_b0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinbiochem.2023.110688_b0240","unstructured":"medicine, I.f.o.c.c.a.l. bnp nt probnp and mr proanp assays. 2021; Available from: https:\/\/ifcc.web.insd.dk\/media\/479203\/bnp-nt-probnp-and-mr-proanp-assays-analytical-characteristics-designated-by-manufacturer-v092021-1.pdf."},{"key":"10.1016\/j.clinbiochem.2023.110688_b0245","first-page":"111","article-title":"A primer on model selection using the Akaike Information Criterion","volume":"5","author":"Portet","year":"2020","journal-title":"Infect Dis Model"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110688_b0250","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/jmps.1999.1277","article-title":"Akaike's information criterion and recent developments in information complexity","volume":"44","author":"Bozdogan","year":"2000","journal-title":"J Math Psychol"},{"key":"10.1016\/j.clinbiochem.2023.110688_b0255","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.7717\/peerj-cs.623","article-title":"The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation","volume":"7","author":"Chicco","year":"2021","journal-title":"PeerJ Comput Sci"},{"issue":"6613","key":"10.1016\/j.clinbiochem.2023.110688_b0260","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.abn0910","article-title":"Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure","volume":"377","author":"Cao","year":"2022","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.clinbiochem.2023.110688_b0265","doi-asserted-by":"crossref","first-page":"e021654","DOI":"10.1161\/JAHA.121.021654","article-title":"Nonalcoholic fatty liver disease and risk of heart failure among medicare beneficiaries","volume":"10","author":"Fudim","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110688_b0270","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4093\/dmj.2015.39.1.10","article-title":"Hepatokines as a link between obesity and cardiovascular diseases","volume":"39","author":"Yoo","year":"2015","journal-title":"Diabetes Metab J"},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110688_b0275","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1515\/cclm-2022-0778","article-title":"Differences between high-sensitivity cardiac troponin T and I in stable populations: underlying causes and clinical implications","volume":"61","author":"Eggers","year":"2023","journal-title":"Clin Chem Lab Med"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:10:32Z","timestamp":1762114232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912023002163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":55,"alternative-id":["S0009912023002163"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110688","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The liver-heart axis in patients with severe obesity: The association between liver fibrosis and chronic myocardial injury may be explained by shared risk factors of cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"110688"}}